DATA FORM FOR CANCER STAGING - NEPHROBLASTOMA
Form # 785-1-056
| CLIN | PATH | DEFINITIONS | ||
| PRIMARY TUMOR (T) | ||||
| TX | Primary tumor cannot be assessed | |||
| T0 | No evidence of primary tumor | |||
| T1 | Unilateral tumor 80 cm2 or less in area (including kidnes)* | |||
| T2 | Unilateral tumor more than 80 cm2 in area (including kidney)* | |||
| T3 | Unilateral tumor rupture before treatment | |||
| T4 | Bilateral tumors | |||
| *Note: The area is calculated by multiplying the vertical and horizontal dimensions of the radiologic shadow of the tumor and kidney. | ||||
| LYMPH NODE (N) | ||||
| NX | Regional lymph nodes cannot be assessed | |||
| N0 | No regional lymph node metastasis | |||
| N1 | Regional lymph node metastasis | |||
| DISTANT METASTASIS (M) | ||||
| MX | Presence of distant metastasis cannot be assessed | |||
| M0 | No distant metastasis | |||
| M1 | Distant metastasis | |||
| PRIMARY TUMOR (PT) | ||||
| pTX | Primary tumor cannot be assessed | |||
| pT0 | No evidence of primary tumor | |||
| pT1 | Intrarenal tumor completely encapsulated; excision complete and margins histologically free | |||
| pT2 | Tumor invades beyond the capsule or renal parenchyma;* excision complete | |||
| pT3 | Tumor invades beyond the capsule or renal parenchyma;* excision incomplete or preoperative or operative rupture | |||
| pT3a | Microscopic residual tumor limited to tu mor bed | |||
| pT3b | Macroscopicresidual tumor or spillage or malignant as cites | |||
| pT3c | Surgical exploration only, tumor not resected | |||
| pT4 | Bilateral tumors | |||
| *Note: This includes breach of the renal capsule or tumor seen microscopically outside the capsule; tumor adhesions microscopically confirmed; infiltrations of or tumor thrombus within the renal vessels outside the kidney; and infiltration of the renal pelvis and/or ureter, peripelvic, and pericalyceal fat. | ||||
| LYMPH NODE (PN) | ||||
| pNX | Regional lymph nodes cannot be assessed | |||
| pN0 | No regional lymph node metastasis | |||
| pN1 | Regional lymph node metastasis | |||
| pN1a | Regional lymph node metastasis completely resected | |||
| PN1b | Regional lymph node metastasis incompletely resected | |||
| DISTANT METASTASIS (PM) | ||||
| pMX | Presence of distant metastasis cannot be assessed | |||
| pM0 | No distant metastasis | |||
| pM1 | Distant metastasis | |||
THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.
| CLIN | PATH | CLINICAL STAGE GROUPING (cTNM) | |||
| I | T1 | N0 | M0 | ||
| II | T2 | N0 | M0 | ||
| III | T1 | N1 | M0 | ||
| T2 | N1 | M0 | |||
| T3 | Any N | M0 | |||
| IVA | T1 | Any N | M1 | ||
| T2 | Any N | M1 | |||
| T3 | Any N | M1 | |||
| IVB | T4 | Any N | Any M | ||
| Pathologic Stage Grouping (pTNM) | |||||
| I | pT1 | pN0 | M0 | ||
| II | pT1 | pN1a | M0 | ||
| pT2 | pN0 | M0 | |||
| pT2 | pN1a | M0 | |||
| IIIA | pT3a | pN0 | M0 | ||
| pT3a | pN1a | M0 | |||
| IIIB | pT1 | pN1b | M0 | ||
| pT2 | pN1b | M0 | |||
| pT3a | pN1b | M0 | |||
| pT3b | Any pN | M0 | |||
| pT3c | Any pN | M0 | |||
| IVA | pT1 | Any pN | M1 | ||
| pT2 | Any pN | M1 | |||
| pT3a | Any pN | M1 | |||
| pT3b | Any pN | M1 | |||
| pT3c | Any pN | M1 | |||
| IVB | pT4 | Any pN | Any M | ||
| Comments: |
| Patient Name: |